ARCHIVES

Bristol-Myers Squibb To Purchase DuPont Pharmaceuticals For $7.8 Billion.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Study: Negative HPV Test More Accurate than Negative Pap Test In Predicting Cervical Cancer Risk

July 25, 2014

NCAB To Hear Details Of New Grant Program, Hanna’s Frederick Plans

November 15, 1974

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992

Boston Study Finds Adenocarcinoma Of Esophagus Increasing

July 14, 1989

Two Phase II Trials Display Ramucirumab Potential Efficacy

October 26, 2012